3rd Quarter - Report

AMERICAN SOCIETY OF CONSULTANT PHARMACISTS for AMERICAN SOCIETY OF CONSULTANT PHARMACISTS

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 20, 2015 $40,000 Replaced
3rd Quarter - Amendment Jul 20, 2017 $40,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Social Security Act, Pharmacist Provider Status (H.R. 592/S.314-Pharmacy and Medically Underserved Areas Enhancement Act, amends sec. 1861 (s)(2) of the SSA (Medicare)) Pharmacy lock-in (H.R. 6 section 3141-Medicare Part D Patient Safety and Drug Abuse Prevention, amends Sec. 1860D-4(c) of the SSA)(Stopping Medication Abuse and Protecting Seniors Act of 2015, amend title XVIII of the Social Security Act)

LobbyistCovered position, as disclosed
ARNOLD CLAYMAN Vice President of Pharmacy Practice & Government Affairs
PETER RANKIN New Director, Policy and Advocacy

Contacted: Food & Drug Administration (FDA); SENATE; Centers For Disease Control & Prevention (CDC); Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: S. 314 (114th), H.R. 6 (114th), H.R. 592 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.